Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Development of Novel CD138 Antigen-Specific Peptide Capable of Eliciting Myeloma-Specific Cytotoxic T Lymphocytes Response.

Jooeun Bae, PhD, Jeff Martinson, BS, Tai Yu-Tzu, PhD, Paola Neri, MD, Pierfrancesco Tassone, MD, Xianfeng Li, BS, Rory Coffey, BS, Zhinan Xia, PhD, Rao Prabhala, PhD, Kenneth Anderson, MD, Nikhil Munshi, MD

Blood (2005) 106 (11): 3465.

https://doi.org/10.1182/blood.V106.11.3465.3465

Published: 2005

Journal Articles

Highly Efficient Presentation of Endogenously Processed Class I Peptides by Artificial APC for the Generation of Effective Anti-Tumor Responses.

Naoto Hirano, MD. PhD, Marcus O. Butler, MD, Zhinan Xia, PhD, Lee M. Nadler, MD

Blood (2004) 104 (11): 1355.

https://doi.org/10.1182/blood.V104.11.1355.1355

Published: 2004

Journal Articles

Somatic Hypermutation Does Not Increase the Binding Affinity of Ig Derived Peptides to MHC Class I or II - Implications for Ig Peptide Vaccination Strategies.

Katja Mauerer, MD, David Zahrieh, MSc, Sascha Ansen, MD, Aihong Li, MD, PhD, Zhinan Xia, PhD, John G. Gribben, MD DSc

Blood (2004) 104 (11): 960.

https://doi.org/10.1182/blood.V104.11.960.960

Published: 2004

Journal Articles

γ-Globin, a Tumor-Associated Antigen for Juvenile Myelomonocytic Leukemia (JMML): A Cell-Based Approach To Identify Tumor Antigenic Epitopes That Are Naturally Processed and Presented.

Naoto Hirano, MD, PhD, Marcus O. Butler, MD, Zhinan Xia, PhD, Seiji Kojima, MD3, Lee M. Nadler, MD

Blood (2004) 104 (11): 3418.

https://doi.org/10.1182/blood.V104.11.3418.3418

Published: 2004

Journal Articles

Mapping Low Molecular Weight Plasma Proteome of Chronic Lymphoblastic Leukemia Patients Using MALDI-TOF Mass Spectrometry.

Jianbiao Zhou, MD MSc, Zhinan Xia, PhD, Aihong Li, MD PhD, John G. Gribben, MD DSc

Blood (2004) 104 (11): 1910.

https://doi.org/10.1182/blood.V104.11.1910.1910

Published: 2004

NARROW

Development of Novel CD138 Antigen-Specific Peptide Capable of Eliciting Myeloma-Specific Cytotoxic T Lymphocytes Response.

Highly Efficient Presentation of Endogenously Processed Class I Peptides by Artificial APC for the Generation of Effective Anti-Tumor Responses.

Somatic Hypermutation Does Not Increase the Binding Affinity of Ig Derived Peptides to MHC Class I or II - Implications for Ig Peptide Vaccination Strategies.

γ-Globin, a Tumor-Associated Antigen for Juvenile Myelomonocytic Leukemia (JMML): A Cell-Based Approach To Identify Tumor Antigenic Epitopes That Are Naturally Processed and Presented.

Mapping Low Molecular Weight Plasma Proteome of Chronic Lymphoblastic Leukemia Patients Using MALDI-TOF Mass Spectrometry.

Email alerts

ASH Publications

American Society of Hematology

Development of Novel CD138 Antigen-Specific Peptide Capable of Eliciting Myeloma-Specific Cytotoxic T Lymphocytes Response.

Highly Efficient Presentation of Endogenously Processed Class I Peptides by Artificial APC for the Generation of Effective Anti-Tumor Responses.

Somatic Hypermutation Does Not Increase the Binding Affinity of Ig Derived Peptides to MHC Class I or II - Implications for Ig Peptide Vaccination Strategies.

γ-Globin, a Tumor-Associated Antigen for Juvenile Myelomonocytic Leukemia (JMML): A Cell-Based Approach To Identify Tumor Antigenic Epitopes That Are Naturally Processed and Presented.

Mapping Low Molecular Weight Plasma Proteome of Chronic Lymphoblastic Leukemia Patients Using MALDI-TOF Mass Spectrometry.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only